Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E van Meegen

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Nederlands Tijdschrift Voor Geneeskunde|October 14, 2006
[Partial resistance to acenocoumarol and phenprocoumon caused by enzyme polymorphism]E B Wilms, R F Veldkamp, E van Meegen, et al.
Thrombosis and Haemostasis|June 3, 1998
Effect of evacuated blood collection tubes on thromboplastin calibrationA M van den Besselaar, J Meeuwisse-Braun, E Witteveen, et al.
Clinical Pharmacology and Therapeutics|June 15, 2001
Drug interactions as a cause of overanticoagulation on phenprocoumon or acenocoumarol predominantly concern antibacterial drugsF J Penning-van Beest, E van Meegen, F R Rosendaal, et al.
Thrombosis and Haemostasis|August 28, 2001
Characteristics of anticoagulant therapy and comorbidity related to overanticoagulationF J Penning-van Beest, E van Meegen, F R Rosendaal, et al.
Journal of Clinical Pharmacology|November 10, 1998
Lack of interaction between tramadol and coumarinsJ K Boeijinga, E van Meegen, R van den Ende, et al.
Lancet (London, England)|December 6, 1997
Is there interaction between tramadol and phenprocoumon?J K Boeijinga, E van Meegen, R van den Ende, et al.
British Journal of Haematology|March 2, 1999
Course of the international Normalized Ratio in response to oral vitamin K1 in patients overanticoagulated with phenprocoumonF J Penning-van Beest, F R Rosendaal, D E Grobbee, et al.
Journal of Hepatology|November 7, 1999
Determination of serum liver tests during therapy with coumarin anticoagulantsF J Penning-van Beest, K K Aben, E van Meegen, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|November 21, 2002
Levels of vitamin K-dependent procoagulant and anticoagulant proteins in over-anticoagulated patientsF J Penning-van Beest, E B Gómez García, F J van der Meer, et al.
Clinical Pharmacology and Therapeutics|December 29, 2006
VKORC1 and CYP2C9 genotypes and phenprocoumon anticoagulation status: interaction between both genotypes affects dose requirementT Schalekamp, B P Brassé, J F M Roijers, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Nederlands Tijdschrift Voor Geneeskunde|October 14, 2006
[Partial resistance to acenocoumarol and phenprocoumon caused by enzyme polymorphism]E B Wilms, R F Veldkamp, E van Meegen, et al.
Thrombosis and Haemostasis|June 3, 1998
Effect of evacuated blood collection tubes on thromboplastin calibrationA M van den Besselaar, J Meeuwisse-Braun, E Witteveen, et al.
Clinical Pharmacology and Therapeutics|June 15, 2001
Drug interactions as a cause of overanticoagulation on phenprocoumon or acenocoumarol predominantly concern antibacterial drugsF J Penning-van Beest, E van Meegen, F R Rosendaal, et al.
Thrombosis and Haemostasis|August 28, 2001
Characteristics of anticoagulant therapy and comorbidity related to overanticoagulationF J Penning-van Beest, E van Meegen, F R Rosendaal, et al.
Journal of Clinical Pharmacology|November 10, 1998
Lack of interaction between tramadol and coumarinsJ K Boeijinga, E van Meegen, R van den Ende, et al.
Lancet (London, England)|December 6, 1997
Is there interaction between tramadol and phenprocoumon?J K Boeijinga, E van Meegen, R van den Ende, et al.
British Journal of Haematology|March 2, 1999
Course of the international Normalized Ratio in response to oral vitamin K1 in patients overanticoagulated with phenprocoumonF J Penning-van Beest, F R Rosendaal, D E Grobbee, et al.
Journal of Hepatology|November 7, 1999
Determination of serum liver tests during therapy with coumarin anticoagulantsF J Penning-van Beest, K K Aben, E van Meegen, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|November 21, 2002
Levels of vitamin K-dependent procoagulant and anticoagulant proteins in over-anticoagulated patientsF J Penning-van Beest, E B Gómez García, F J van der Meer, et al.
Clinical Pharmacology and Therapeutics|December 29, 2006
VKORC1 and CYP2C9 genotypes and phenprocoumon anticoagulation status: interaction between both genotypes affects dose requirementT Schalekamp, B P Brassé, J F M Roijers, et al.
Pageof 2